Ceftaroline applications for therapy in the United States.
Publication
, Journal Article
Corey, GR; Jones, RN
Published in: Clin Infect Dis
September 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
September 2012
Volume
55 Suppl 3
Start / End Page
S171 / S172
Location
United States
Related Subject Headings
- United States
- Microbiology
- Humans
- Drug Approval
- Clinical Trials as Topic
- Cephalosporins
- Anti-Bacterial Agents
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Corey, G. R., & Jones, R. N. (2012). Ceftaroline applications for therapy in the United States. Clin Infect Dis, 55 Suppl 3, S171–S172. https://doi.org/10.1093/cid/cis558
Corey, G Ralph, and Ronald N. Jones. “Ceftaroline applications for therapy in the United States.” Clin Infect Dis 55 Suppl 3 (September 2012): S171–72. https://doi.org/10.1093/cid/cis558.
Corey GR, Jones RN. Ceftaroline applications for therapy in the United States. Clin Infect Dis. 2012 Sep;55 Suppl 3:S171–2.
Corey, G. Ralph, and Ronald N. Jones. “Ceftaroline applications for therapy in the United States.” Clin Infect Dis, vol. 55 Suppl 3, Sept. 2012, pp. S171–72. Pubmed, doi:10.1093/cid/cis558.
Corey GR, Jones RN. Ceftaroline applications for therapy in the United States. Clin Infect Dis. 2012 Sep;55 Suppl 3:S171–S172.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
September 2012
Volume
55 Suppl 3
Start / End Page
S171 / S172
Location
United States
Related Subject Headings
- United States
- Microbiology
- Humans
- Drug Approval
- Clinical Trials as Topic
- Cephalosporins
- Anti-Bacterial Agents
- 11 Medical and Health Sciences
- 06 Biological Sciences